3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Leukemia, Myeloid, Acute
1
Interventions
Specimen Handling
481
pembrolizumab
454
Magnetic Resonance Spectroscopy
419
Carboplatin
321
Cyclophosphamide
314
Biopsy
272
Cisplatin
264
Radiotherapy
239
Paclitaxel
226
Gemcitabine
222
Bevacizumab
212
Nivolumab
189
fludarabine
183
venetoclax
172
Drug Therapy
165
Dexamethasone
157
Blood Specimen Collection
156
Oxaliplatin
154
Injections
152
Capecitabine
152
Fluorouracil
144
Docetaxel
142
Standard of Care
136
Radiosurgery
136
Rituximab
125
Pemetrexed
115
durvalumab
113
atezolizumab
110
Leucovorin
110
Radiation
105
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
bomedemstat
×
1 year
×
Clear all
NCT06351631
2026-04-02
MK-3543-017
Merck Sharp & Dohme LLC
Phase 3
Recruiting
400 enrolled
NCT05597306
2026-01-08
VenBom
University of Miami
Phase 1
Recruiting
18 enrolled